Mao Helen Huihua - Net Worth and Insider Trading
Mao Helen Huihua Net Worth
The estimated net worth of Mao Helen Huihua is at least $971 Million dollars as of 2025-01-09. Mao Helen Huihua is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc and owns about 34,858,400 shares of CanSino Biologics Inc (HKSE:06185) stock worth over $971 Million. Details can be seen in Mao Helen Huihua's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mao Helen Huihua has not made any transactions after 2024-12-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mao Helen Huihua
Mao Helen Huihua Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mao Helen Huihua owns 1 companies in total, including CanSino Biologics Inc (HKSE:06185) .
Click here to see the complete history of Mao Helen Huihua’s form 4 insider trades.
Insider Ownership Summary of Mao Helen Huihua
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2024-12-04 | 2201 Interest of corporation controlled by you |
Mao Helen Huihua Latest Holdings Summary
Mao Helen Huihua currently owns a total of 1 stock. Mao Helen Huihua owns 34,858,400 shares of CanSino Biologics Inc (HKSE:06185) as of December 3, 2024, with a value of $971 Million.
Latest Holdings of Mao Helen Huihua
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:06185 | CanSino Biologics Inc | 2024-12-03 | 34,858,400 | 27.85 | 970,806,440 |
Holding Weightings of Mao Helen Huihua
Mao Helen Huihua Form 4 Trading Tracker
According to the SEC Form 4 filings, Mao Helen Huihua has made a total of 2 transactions in CanSino Biologics Inc (HKSE:06185) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in CanSino Biologics Inc is the sale of 0 shares on December 3, 2024, which brought Mao Helen Huihua around $0.
Insider Trading History of Mao Helen Huihua
- 1
Mao Helen Huihua Trading Performance
Mao Helen Huihua Ownership Network
Mao Helen Huihua Owned Company Details
What does CanSino Biologics Inc do?
Who are the key executives at CanSino Biologics Inc?
Mao Helen Huihua is the 2201 Interest of corporation controlled by you of CanSino Biologics Inc. Other key executives at CanSino Biologics Inc include 2501 Other Yu Xuefeng , 2202 Interest of your spouse Chao Shou Bai , and 2201 Interest of corporation controlled by you The Capital Group Companies, Inc. .
CanSino Biologics Inc (HKSE:06185) Insider Trades Summary
Over the past 18 months, Mao Helen Huihua made 1 insider transaction in CanSino Biologics Inc (HKSE:06185) with a net sale of 0. Other recent insider transactions involving CanSino Biologics Inc (HKSE:06185) include a net sale of 2,876,600 shares made by The Capital Group Companies, Inc. , a net purchase of 781,600 shares made by Jpmorgan Chase & Co. , and a net purchase of 48,000 shares made by Chao Shou Bai .
In summary, during the past 3 months, insiders sold 0 shares of CanSino Biologics Inc (HKSE:06185) in total and bought 48,000 shares, with a net purchase of 48,000 shares. During the past 18 months, 2,876,600 shares of CanSino Biologics Inc (HKSE:06185) were sold and 859,600 shares were bought by its insiders, resulting in a net sale of 2,017,000 shares.
CanSino Biologics Inc (HKSE:06185)'s detailed insider trading history can be found in Insider Trading Tracker table.
CanSino Biologics Inc Insider Transactions
Mao Helen Huihua Mailing Address
Above is the net worth, insider trading, and ownership report for Mao Helen Huihua. Currently GuruFocus does not have mailing address information for Mao Helen Huihua.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
